OMB
.report
Search
Focus Group Study of Healthcare Provider Knowledge of Biosimilar Biological Products - Phase 2
Testing Communications on Biological Products
OMB: 0910-0687
IC ID: 217649
OMB.report
HHS/FDA
OMB 0910-0687
ICR 201412-0910-003
IC 217649
( )
Documents and Forms
Document Name
Document Type
Recruitment Screener.doc
Other-Questionnaire
OMB Justification for Generic Clearance for Focus Group Study of Healthcare Provider Knowledge of BPP - Phase 2.doc
OMB Justification for Generic Clearance for Focus Group Study of Healthcare Provider Knowledge of Biosimilar Biological Products
IC Document
Interview Guide - Template.doc
Interview Guide
IC Document
Consent Form - Pharmacists.docx
Consent Form - Pharmacists
IC Document
Consent Form - Physicians.docx
Consent Form - Physicians
IC Document
CITI IRB Training Certificate (Rupert).pdf
Training Certificate (Rupert)
IC Document
CITI IRB Training Certificate (Scales).pdf
Training Certificate (Scales)
IC Document
CITI_Lappin.pdf
Training Certificate (Lappin)
IC Document
RE Incentives.msg
Recommendation on Incentives from OMB
IC Document
Information Collection (IC) Details
View Information Collection (IC)
IC Title:
Focus Group Study of Healthcare Provider Knowledge of Biosimilar Biological Products - Phase 2
Agency IC Tracking Number:
OC
IC Status:
New
Obligation to Respond:
Voluntary
CFR Citation:
Information Collection Instruments:
Document Type
Form No.
Form Name
Instrument File
URL
Available Electronically?
Can Be Submitted Electronically?
Electronic Capability
Other-Questionnaire
Recruitment Screener.doc
No
Paper Only
Federal Enterprise Architecture Business Reference Module
Line of Business:
Health
Subfunction:
Health Care Services
Privacy Act System of Records
Title:
FR Citation:
Number of Respondents:
81
Number of Respondents for Small Entity:
0
Affected Public:
Private Sector
Private Sector:
Businesses or other for-profits
Percentage of Respondents Reporting Electronically:
0 %
Approved
Program Change Due to New Statute
Program Change Due to Agency Discretion
Change Due to Adjustment in Agency Estimate
Change Due to Potential Violation of the PRA
Previously Approved
Annual Number of Responses for this IC
81
0
81
0
0
0
Annual IC Time Burden (Hours)
29
0
29
0
0
0
Annual IC Cost Burden (Dollars)
0
0
0
0
0
0
Documents for IC
Title
Document
Date Uploaded
OMB Justification for Generic Clearance for Focus Group Study of Healthcare Provider Knowledge of Biosimilar Biological Products
OMB Justification for Generic Clearance for Focus Group Study of Healthcare Provider Knowledge of BPP - Phase 2.doc
07/24/2015
Interview Guide
Interview Guide - Template.doc
07/24/2015
Consent Form - Pharmacists
Consent Form - Pharmacists.docx
07/24/2015
Consent Form - Physicians
Consent Form - Physicians.docx
07/24/2015
Training Certificate (Rupert)
CITI IRB Training Certificate (Rupert).pdf
07/24/2015
Training Certificate (Scales)
CITI IRB Training Certificate (Scales).pdf
07/24/2015
Training Certificate (Lappin)
CITI_Lappin.pdf
07/24/2015
Recommendation on Incentives from OMB
RE Incentives.msg
07/24/2015
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.